Anthracyclines are effective in the treatment of leukemia, but their use is limited because of cardiotoxicity. Liposomal daunorubicin (L-DNR) is potentially less cardiotoxic than daunorubicin (DNR). We compared in vitro cytotoxicity in pediatric acute leukemia samples and found no significant differences between cytotoxicity of DNR and L-DNR.
|Number of pages||2|
|Publication status||Published - Nov 2006|
- Drug sensitivity
- Liposomal daunombicin
- Pediatric acute leukemia